| <--
By name J |
|
|
|
|
Company
Name |
City |
State |
Country |
Short
Summary |
| Kala Pharmaceuticals |
Waltham |
MA |
USA |
Kala Pharmaceuticals is focued on the research and development of ophthalmic treatments. |
| Kalexsyn |
Kalamazoo |
MI |
USA |
Kalexsyn is contract research organization (CRO) focused on providing discovery and development services. |
| KaloBios Pharmaceuticals |
South San Francisco |
CA |
USA |
KaloBios is focused on the development of antibody therapeutics in autoimmunity, infectious disease, and cancer. |
| Kalon Biotherapeutics |
College Statioin |
TX |
USA |
Kalon Biotherapeutics contract research organization (CRO) which is focused on biologics development and manufacturing services. |
| Kalos Therapeutics |
San Diego |
CA |
USA |
Kalos Therapeutics is focused on the research and development of atrial natriuretic peptides (ANPs) to treat patients with cancer. |
| Kane Biotech |
Winnipeg |
MB |
CAN |
Kane Biotech is focused on the research, development, and commercialization of products to prevent and disperse biofilms. |
| Karus Therapeutics |
Abingdon |
|
UK |
Karus Therapeutics is focused on the research and development of small molecule drugs to treat patients with immune/inflammatory disorders and cancer. |
| KBI Biopharma |
Durham |
NC |
USA |
KBI Biopharma is focused on contract biopharmaceutical development, providing services from preclinical studies to NDA/Commercial launch. |
| KemPharm |
Coralville |
IA |
USA |
KemPharm is focused on the discovery and development of new, safer therapies for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), pain, and cardiovascular disease |
| Kereos |
St. Louis |
MO |
USA |
Kereos is focused on development ligand-targeted emulsion candidates targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease. |
| Keryx Biopharmaceuticals |
New York |
NY |
USA |
Keryx Biopharmaceuticals is focused on the acquisition, development, and commercialization of products for the treatment of patients with cancer and renal disease. |
| Keystone Nano |
State College |
PA |
USA |
Keystone Nano is focused on the development of therapeutic and diagnostic applications for their proprietary 5 to 50 nm-composite particles. |
| Kibow Biotech |
Newtown Square |
PA |
USA |
Kibow Biotech is focused on the research, development, and commercialization of probiotic dietary supplements for kidney and immune health. |
| Kineta |
Seattle |
WA |
USA |
Kineta is focused on discovery, research and development of broad spectrum antiviral therapies for the treatment of RNA viruses. |
| Kips Bay Medical |
Minneapolis |
MN |
USA |
Kips Bay Medical is focused on development and commercialization of therapeutic vascular technologies to the cardiac surgeon. |
| Kite Pharma |
Santa Monica |
CA |
USA |
Kite Pharma is focused on the research and development of immune-based targeted therapies to treat patients with cancer. |
| Kiyatec |
Greenville |
SC |
USA |
Kiyatec is focused on the development and commercialization of a proprietary 3D cell culture technology. |
| KMT Hepatech |
Edmonton |
AB |
CAN |
KMT Hepatech is focused on providing in vivo research services to companies who are in preclinical development of Hepatitis C (HCV), Hepatitis B (HBV) and Malaria therapeutics and vaccines, utilizing a transgenic mouse with a humanized liver. |
| Kolltan Pharmaceuticals |
New Haven |
CT |
USA |
Kolltan Pharmaceuticals is focused on the development of monoclonal antibody and small-molecule drugs targeting receptor tyrosine kinases. |
| Koronis Pharmaceuticals |
Seattle |
WA |
USA |
Koronis Pharmaceuticals is focused on the research and development of antiviral therapeutics which increase the rate of viral mutation. |
| Kowa Research Institute |
Morrisville |
NC |
USA |
Kowa Research Institute is focused on the clinical development of Kowa’s new drugs in the United States. |
| KWS BioTest |
Bristol |
|
UK |
KWS BioTest is a contract research organization (CRO) providing preclinical research and development services to clients in the biotechnology and pharmaceutical industries. |
| <--
By name J |
|
|
|
